| [1]ZHANG Z X,ROMAN G C,HONG Z,et al.Parkinson’s disease in China:prevalence in Beijing,Xi’an,and Shanghai[J].Lancet,2005,365:595-597.
[2]廖品君.甲磺酸雷沙吉兰联合左旋多巴治疗运动症状有波动的原发性帕金森病的疗效观察[J].实用心脑肺血管病杂志,2014,22(9):78-79.
LIAO P J.The curative effect of rasagiline mesylate combined with levodopa in the treatment of motor symptoms with fluctuations in idiopathic Parkinson’s disease[J].Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease,2014,22(9):78-79.DOI:10.3969/j.issn.1008-5971.2014.09.037.
[3]MARTINEZ-MARTIN P,SCHAPIRA A H,STOECHI F,et al.Prevalence of non-motor symptoms in Parkinson’s disease in an international setting:study using non-motor symptoms questionnaire in 545 patients[J].Mov Disord,2007,22(11):1623-1629.
[4]中华医学会神经病学分会运动障碍及帕金森病学组.帕金森病的诊断[J].中华神经科杂志,2006,39(6):408-409.
The Chinese Medical Association Neurological Branch Movement Disorders and Parkinson’s Disease Group.Diagnosis of Parkinson’s disease[J].Chinese Journal of Neurology,2006,39(6):408-409.DOI:10.3760/j.issn:1006-7876.2006.06.024.
[5]HOEHN M M,YAHR M D.Parkinsonism:onset,progression,and mortality[J].Neurology,2001,57(3):11-26.
[6]BORROMEI A,CARAMELLI R,CHIEREGATTI G,et al.Ability and fitness to drive of Parkinson’s disease patients[J].Funct Neurol,1999,14(4):227-234.
[7]陈海波.统一帕金森病评分量表[J].中华老年医学杂志,1999,18(1):61-63.
CHEN H B.Unified Parkinson’s disease rating scale[J].Chinese Journal of Geriatric Medicine,1999,18(1):61-63.
[8]CHAUDHURI K R,MARTINEZ-MARTIN P,SCHAPIRA A H,et al.International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson’s disease:the NMSQuest study[J].Mov Disord,2006,21(7):916-923.
[9] BARONE P, ANTONINI A, COLOSIMO C, et al. The PRIAMO study: a multicenter assessment of non-motor symptoms and their impact on quality of life in Parkinson's disease [J]. Mov Disord, 2009,24 (11):1641-1649.
[10] KHOO TK, YARNALLA J, DUNCAN GW, et al. The spectrum of nonmotor symptoms in early Parkinson disease [J]. Neurology, 2013,80 (3):276-281.
[11] 张国平,王莉莉.血清尿酸水平与帕金森病患者非运动症状的相关性及其临床意义研究 [J].实用心脑肺血管病杂志,2015,23 (12):24-26.
ZHANG GP, WANG LL. Correlation between serum uric acid level and non-motor symptoms of patients with Parkinson's disease and its clinical significance [J]. Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease, 2015,23 (12):24-26.
[12] DUNCAN GW, KHOO TK, YARNALLA J, et al. Health related quality of life in early Parkinson's disease: the impact of nonmotor symptoms [J]. Mov Disord, 2014,29 (2):195-202.
[13] TSUBOI Y, YAMADA T, CHAUDHURI RK, et al. Comparison profile of non-motor symptoms in Japanese patients with PD with European patients and healthy controls. Extension of the NMSQuest study [J]. Mov Disord, 2006,21 (Suppl 115):S648.
[14] SCHRAG A, HORSFALL, WALTERS K, et al. Prediagnostic presentations of Parkinson's disease in primary care: a case-control study [J]. Lancet Neurol, 2015,14 (1):57-64.
[15] BREEN KC, DRUTYTE G. Non-motor symptoms of Parkinson's disease: the patient's perspective [J]. J Neural Transm, 2013,120 (4):531-535.
[16] SCHRAG A. Quality of life and depression in Parkinson's disease [J]. J Neurol Sci, 2006,248 (1/2):151-157.
[17] FORSSAE B, LARSEN JP, WENTZEL-LARSEN T, et al. A 12-year population-based study of psychosis in Parkinson disease [J]. Arch Neurol, 2010,67 (8):996-1000.
[18] BRAAK H, TREDICI KD, RUB U, et al. Staging of brain pathology related to sporadic Parkinson's disease [J]. Neurobiol Aging, 2003,24 (2):197-210.
[19] STORCH A, SCHNEIDER CB, WOLZ M, et al. Nonmotor fluctuations in Parkinson disease: severity and correlation with motor complications [J]. Neurology, 2013,80 (9):800-809. |